Fresenius Medical Care AG & Co. KGaA (“the company”, “FMC” or “Fresenius Medical Care”) announced a leadership change in North America. William (Bill) Valle (56) has been appointed the new Chief Executive Officer (CEO) of North America, effective January 16, 2017. Bill Valle will succeed Ronald (Ron) Kuerbitz (56), who is joining agilon health as Chief Executive Officer. Bill Valle serves since 2014 as Executive Vice President responsible for the Dialysis Service Business of Fresenius Medical Care North America (FMCNA) — the business segment of the company as well as its Vascular Access business. In that position Bill was responsible for the successful management of more than 2,400 outpatient facilities and home programs and 1,400 inpatient programs across the United States and Puerto Rico. Bill Valle joined FMCNA in 2009 with 22 years’ experience in the dialysis industry, holding executive positions at several dialysis companies including Gambro Healthcare Inc.